Incredible as it may sound, Harvard Drug Group immediately sued the Drug Enforcement Administration (DEA) after its license suspension…and won an impressive victory.
Here’s the lead from the company’s press release Harvard Drug Group Gains Injunctive Relief From DEA:
“Today, the Drug Enforcement Administration and U.S. Attorney’s Office, and Harvard Drug Group announced their agreement to immediately modify the suspension, upon certain conditions, of Harvard’s registration to distribute schedule III through V controlled substances out of its Livonia Distribution Center, and a mutual commitment to commence discussions, towards resolution of the issues raised in the DEA’s suspension order. The suspension remains as to schedule II controlled substances.”You can also read this letter from Chairman and CEO Randy Friedman. No press release or retraction from the DEA, naturally.
I wonder if the executives at Cardinal Health (NYSE:CAH) are kicking themselves for not being more aggressive back in 2007. Lawyer’s remorse?
Randy won't be breaking rocks in the hot sun, but we can still celebrate the first day of summer 2010 with The Clash!